Genotyping of Measles Virus in Clinical Specimens on the Basis of Oligonucleotide Microarray Hybridization Patterns

An oligonucleotide microarray hybridization method for identification of most known measles virus (MV) genotypes was developed. Like the conventional genotyping method, the microarray relied on detecting sequence differences in the 450-nucleotide region coding for the COOH-terminal 150 amino acids o...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Clinical Microbiology Vol. 44; no. 10; pp. 3752 - 3759
Main Authors: Neverov, Alexander A, Riddell, Michaela A, Moss, William J, Volokhov, Dmitriy V, Rota, Paul A, Lowe, Luis E, Chibo, Doris, Smit, Sheilagh B, Griffin, Diane E, Chumakov, Konstantin M, Chizhikov, Vladimir E
Format: Journal Article
Language:English
Published: Washington, DC American Society for Microbiology 01-10-2006
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:An oligonucleotide microarray hybridization method for identification of most known measles virus (MV) genotypes was developed. Like the conventional genotyping method, the microarray relied on detecting sequence differences in the 450-nucleotide region coding for the COOH-terminal 150 amino acids of the nucleoprotein (N). This region was amplified using PCR primers binding to all known MV genotypes. The microarray included 71 pairs of oligonucleotide probes (oligoprobes) immobilized on glass slides. Each pair consisted of a genotype-specific oligoprobe, which matched the sequence of only one target genotype, and a control oligoprobe, which contained mismatches at the nucleotide positions unique to this genotype. A pattern recognition algorithm based on cluster analysis of the ratios of hybridization signals from specific and control oligoprobes was used to identify the specific MV genotype. Following the initial validation, the method was used for rapid genotyping of two panels of coded samples. The results of this study showed good sensitivity (90.7%), specificity (100%), and genotype agreement (91.8%) for the new method compared to the results of genotyping conducted using phylogenetic analysis of viral sequences of the C terminus of the N gene. In addition, the microarray demonstrated the ability to identify potential new genotypes of MV based on the similarity of their hybridization patterns with those of known MV genotypes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Corresponding author. Mailing address: HFM-470, LMD/CBER, FDA, 1401 Rockville Pike, Rockville, MD 20852-1448. Phone: (301) 827-7388. Fax: (301) 827-9531. E-mail: alexander.neverov@fda.hhs.gov.
ISSN:0095-1137
1098-660X
1098-5530
DOI:10.1128/JCM.00998-06